Kerry brings to Atea over 20 years of Quality experience associated with the clinical development and commercialization of pharmaceutical products and medical devices. Her experience includes the design of quality systems for the oversight of GxP activities and managing numerous Health Authority inspections, which have supported multiple product approvals and launches.
Prior to joining Atea, Kerry built and led Quality teams at Sage Therapeutics, bluebird bio, and Sigilon Therapeutics. Kerry began her career in biomedical research with W.R. Grace and held various Quality Management roles with Organogenesis.
Kerry holds B.S. and M.S. degrees in Plastics Engineering from the University of Massachusetts, Lowell.
Back to Full Team
Atea is a clinical-stage biopharmaceutical company committed to addressing unmet medical needs through novel antiviral treatments.
Copyright © 2023 By Atea Pharmaceuticals. All Rights Reserved. Privacy Policy | Terms of Use